Healthcare -
Biotechnology - NASDAQ - US
$ 19.03
4.62 %
$ 14 B
Market Cap
-82.74
P/E
SMMT - CASH & EQUIVALENTS
Cash & Equivalents SMMT - Summit Therapeutics Inc.
71.4 M
LAST VALUE
-0.26%
2 YEAR CAGR
15.19%
5 YEAR CAGR
35.80%
10 YEAR CAGR